Introduction
Nasopharyngeal carcinoma (NPC), of all human malignancies, is associated most strongly with Epstein-Barr virus (EBV). Multiple episomal copies of the viral genome are found in all poorly differentiated or anaplastic NPCs, irrespective of ethnic origin (zur Hausen et al., 1970; Wolfet al., 1973; Andersson-Anvret et al., 1977) . In Burkitt's lymphoma (BL), the association is much weaker, with 97~ of the tumours in highly endemic areas and only 20~ of tumours in the sporadic form carrying EBV genomes (Rowe & Gregory, 1989) . EBV genomes have not been found in squamous cell carcinomas or other tumour types in the nasopharyngeal region (Sixbey, 1989) . This regular association cannot be due to chance. Most probably, the genetic machinery of EBV predisposes the epithelial precursor cell of NPC to t Permanent address: Shanghai Cancer Institute, 2200 Xie Tu Road, Shanghai, People's Republic of China.
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0001-0360 © 1991 SGM malignant development, either alone or in conjunction with environmental or genetic cofactors. The EBV strains in areas of high NPC incidence, such as Southern China, may be functionally indistinguishable from strains isolated from B cell malignancies, in which case the cofactors are of greater importance to the understanding of the biogenesis of NPC. However, the possibility that EBV strains in areas of high NPC incidence have common functional and genetic differences which cause their different tropisms in relation to malignancy cannot be discounted.
Studies of EBV gene expression in NPC (F~hraeus et al., 1988; Young et al., 1988) reveal that, in addition to Epstein-Barr nuclear antigen (EBNA) 1, which is expressed in all EBV-carrying cells irrespective of phenotype, LMP1 is the only other transformationassociated EBV gene that is expressed in NPC tumour biopsies, and in a majority of cases. EBNAs 2 to 6 appear to be regulated in a B cell-specific fashion, and their expression has not been detected in NPC. As EBNA 1 has not been ascribed any transforming function, LMP1 is the most likely candidate for an EBV gene that participates in the transformation of the nasopharyngeal epithelium in NPC. This assumption is also supported by findings showing that LMP1 transforms established rodent fibroblasts in vitro (Baichwal & Sugden, 1988 , 1989 Wang et al., 1985 Wang et al., , 1988 , alters the phenotype of immortalized human keratinocytes (Fhhraeus et al., 1990a) and inhibits their keratinous differentiation (Dawson et al., 1990) .
To compare NPC isolates with B cell-derived isolates of EBV at the molecular and functional level, we isolated the BNLF-1 (LMP1) gene and its promoter region from a nude mouse-passaged Chinese NPC, CAO (Cao et al., 1987; Fhhreus et al., 1988) , and compared its DNA sequence to those of the B95-8, Raji and C15 LMP1 genes (Baer et al., 1984; Hatfull et al., 1988; Gilligan et al., 1990) . The B95-8 and Raji isolates show a very high degree of similarity in the BNLF-1 gene (97.5~ similarity over the coding sequence, including the two introns), and therefore do not provide clues to the location of conserved and variable regions of the gene. The partial sequence of the LMP1 cDNA from the nude mouse-passaged North African NPC, C 15 , shows even greater similarity with B95-8 than Raji (Gilligan et al., 1990) . Studies of EBV strains isolated from healthy Chinese carriers and NPC biopsies have revealed a number of alterations in different regions of the EBV genome, mainly involving repeated sequences (Lung et al., 1988 (Lung et al., , 1990 Zhang et al., 1989) . Certain genome types appear to represent virus strains prevalent in Asia, particularly Southern China, such as the proposed type C strain which lacks a BamHI site between BamHI W 1" and I 1", and a proposed substrain carrying, in addition, a deletion in BamHI F [strain A/C(f); Lung et al., 1990] .
The experiments presented here demonstrate that CAO expresses a LMP 1 protein larger than that of the B95-8 isolate. Sequence analysis of the BNLF-1 gene cloned from this tumour reveals a conserved overall structure for the CAO LMP1 gene, but with nucleotide changes producing many amino acid substitutions within the first 20 amino acids (aa) of the encoded protein, two deletions and the insertion of three additional 33 bp repeats in the C-terminal part of the protein. The additional repeats alter the size and the proposed structure of the 25K phosphorylated fragment which is cleaved off during processing of the LMP1 protein (Mann & Thorley-Lawson, 1987; Baichwal & Sugden, 1987; Moorthy & Thorley-Lawson, 1990 ). The enhancer and promoter sequence also contains several base substitutions, in particular in the LMP1 transcription control region between nucleotides -240 and -1, relative to the cap site. The absence of an XhoI site in the 5' exon of the CAO BNLF-1 (LMP1) gene is shown to provide a restriction fragment length polymorphism (RFLP) marker that distinguishes the BNLF-1 genes in Chinese EBV-positive NPC biopsies from those in NPC biopsies of African origin. ori ori 3-9 kb Fig. 1 . Map of the 2 SK10 vector. 2 SK10 is a replacement vector with a cloning capacity of 4.5 to 20 kb. It was constructed by inserting restriction site linkers into 2 SK9 (Zabarovsky et al., 1989) to allow the use of BamHI, EcoRI, NaeI and Xhol for cloning. The vector can be selected by red-gam selection, and inserts may be subcloned in a plasmid by simple excision with Sail, ClaI or BspMII, followed by religation at low concentration.
Methods
Tumour material and celllines. CAO is an EBV-positive NPC derived from a 54-year-old male patient from the Shanghai area of China. It has subsequently been propagated as a xenograft in BALB/c nude mice (Cao et al., 1987; F~thraeus et al., 1988) . C15 is a North African NPC established in nude mice (a gift from T. Tursz; see Busson et al., 1988) ; CI5/CBC is a lymphoblastoid cell line obtained by cocultivation of human cord blood lymphocytes with C15 cells (Ernberg et al., 1989) . CBC-SEB-CHI-7 and CBC-SEB-CHI-20 are lymphoblastoid cell lines (LCLs) established by infection of cord blood lymphocytes with EBV from a healthy Chinese donor and a Chinese NPC patient, respectively (Hu et al., 1991) . C121 and C82 are NPC biopsies of North African origin (gifts from T. Tursz); SD and OM are East African NPC biopsies; N8, Nil, N17 and N40 are NPC biopsies from Shanghai, China; N41, N45 and N48 are NPC biopsies from the Guangdong province in southern China (see Fig. 2b ). B95-8 is a line of marmoset lymphocytes transformed with EBV type A from mononucleosis (Shope et al., 1973) ; Jijoye M 13 is an EBV-positive BL cell line carrying an EBV type B strain (Hinuma et al., 1967) ; DG75 is an EBV-negative BL line (Ben-Bassat et al., 1977) ; BJAB is a EBV-negative B cell lymphoma line (Menezes et al., 1975) . Rhek-1 cells are human epidermal keratinocytes transformed by an adenovirus 12 (Adl2)-simian virus 40 (SV40) hybrid expressing SV40 large T and small t antigens, but not Adl2 E1A or E1B proteins (Rhim et al., 1985) . DNA cloning. DNA was extracted from the CAO tumour tissue by standard methods (Sambrook et al., 1989) and cleaved with BamHI for library construction. The phage 2 vector SK 10 ( Fig. 1) was cleaved with EcoRI and BamHI to release and inactivate the stuffer fragment. The short oligonucleotide fragments joining the BamHI sites on the vector arms with the EcoRI sites on the stuffer were removed by precipitating the DNA in 6-5% polyethylene glycol 8000, 0.85 M-NaC1 (Lis, 1980) . One microgram each of the BamHI-cleaved CAO and SK10 vector DNA was ligated at 200 ttg/ml under standard conditions and packaged into phage ~ using a packaging extract (Sambrook et al., 1989) . The primary library contained about 106 independent clones. The library was plated on NM621 (Whittaker et al., 1988 ) cells in 22 x 22 cm dishes at a density of about 105 plaques per plate, and replicated on Hybond-N filters (Amersham). After screening of the filters with the 1.9 kb XhoI fragment of B95-8, containing the coding sequence of the LMP 1 gene (coordinates 167487 to 169423; Baer et al., 1984) , 10 LMPl-positive clones were isolated and analysed. Clone CAO-5 was chosen for further analysis (see below).
The EBV insert in CAO-5 was subcloned by excision from the phage 2 vector using ClaI, (Fig. 1) . Since 2 SKI0 contains the pBR322 origin and the/~-lactamase gene in the sequences flanking the insert, the ClaI (Baer et al., 1984) . All other primers were made from the sequence of EBV strain CAO. fragment yields a plasmid subclone of the insert after recircularization. The LMP1 gene and promoter/enhancer sequences, contained in the SaclI-BamHI fragment corresponding to B95-8 coordinates 170153 to 166614, were subcloned (after adding a BamHI linker to the SaclI site) into the BamHI site of the J124-A8 vector (a gift from L. Rymo), producing the construct J124-CAO-5. The J124-A8 vector is a pSV2-gpt-based eukaryotic expression vector (Mulligan & Berg, 1981 ) with a second SV40 origin and a BamHI cloning site placed between the end of the gpt gene and the SV40 poly(A) site (Fig. 2) . The J 132-G5 plasmid (a gift from L. Rymo) is isogenic with the J124-CAO-5 construct, but carries the B95-8 LMPI gene.
DNA sequencing. Double-stranded plasmids were sequenced (Chen & Seeburg, 1985; Lim & Pene, 1988) using the dideoxynucleotide chain termination method (Sanger et al., 1977) adapted for the use of phage T7 DNA polymerase (Sequenase; USB). Sequencing primers were synthesized on an Applied Biosystems 381A synthesizer, or purchased from Scandinavian Gene Synthesis. Since the LMP1 gene of two virus isolates has been sequenced, only divergent or ambiguous sequences were read on both strands. An average of 200 bases was read off each primer. The sequence and location of each primer used is shown in Table 1 .
Southern blot analysis. For analysis of ~'hoI RFLP (Fig. 2) , 10 p.g of DNA from each biopsy was digested with 40 units of XhoI overnight in the appropriate buffer. After electrophoretic separation, the DNA was transferred from the agarose gel to a nylon filter (Hybond-N; Amersham). The filters were hybridized with the 1.9 kb XhoI fragment of B95-8 containing the LMP1 gene (see above), and labelled with 32p using the Klenow fragment of DNA polymerase I and random hexamers as primers. The EBNA 2B type of EBV was identified using a cloned fragment of Jijoye EBV, covering the 3' half of the EBNA 2B coding exon, as a probe (kindly provided by G. Bornkamm; Addlinger et al., 1985) . Detailed analysis of the structure of the CAO and B95-8 LMP1 genes in viral episomes in the B95-8 cell line and the CAO nude mouse tumour (Fig. 5 ) was performed in a similar fashion, but cleavage products were separated on a 1"5 % agarose gel and the filter was probed with the 1671 bp SmaI fragment, containing the entire B95-8 LMP1 coding sequence (coordinates 169591 to 167920). It should be noted that DNA fragments larger than about 2 kb can not be reliably determined in this experiment owing to the high agarose concentration used to separate the fragments of small size, which were of interest.
Protein analysis by immunoblotting. Cultured cells were dissolved at a ratio of 107 cells/ml in RIPA buffer (150 mM-NaC1, 1% NP40, 0-5~ deoxycholate, 0.1 ~ SDS, 50 mM-Tris-HCl pH 7.5). Tumour material was ground to a powder in liquid nitrogen, solubilized in an appropriate volume of RIPA buffer and the proteins were separated on SDSacrylamide gels (Laemmli, 1970) . Electrophoretic transfer of the protein to nitrocellulose filters (Towbin et al., 1976) and immunoblotting with the anti-LMP1 monoclonal antibody S12 (Mann et aL, 1985) were essentially as described (Fhhraeus et al., 1988) .
Transfection of DNA into human cells. Transient expression of the B95-8 and the CAO LMP1 genes from the expression plasmids J132-G5 and J124-CAO-5, respectively, was achieved by electroporation using the Gene Pulser apparatus (Bio-Rad). The conditions were optimized for each cell line using a chloramphenicol acetyltransferase reporter system. For DG75 cells, 250 V, 960 ~tF resulted in a pulse of 22 to 27 ms, and for B JAB cells, 300 V, 960 l.tF (22 to 27 ms) was used; for Rhek-1 cells, 250 V, 960 ~tF was used. Cells were harvested in log phase, concentrated to 6 × 106 cells/ml in Optimem (Gibco) supplemented with penicillin, streptomycin and glutamine, but without serum. Uncleaved plasmid DNA (10 ~tg) was added to 0.8 ml of cells and the cell suspension was left on ice for 5 to 10 min before electroporation. Immediately after the shock, the cell suspension was stirred briefly with a Pasteur pipette to even out pH gradient effects in the cuvette. The cells were then left on ice for 10 min before plating in 10 ml Iscove's modification of Dulbecco's MEM with 10% foetal calf serum. Cells were harvested for protein analysis 40 h post-transfection.
Results
XhoI restriction site polymorphism in the LMP1 gene of Chinese NPC tumours Fig. 2 shows XhoI site polymorphism in a number of samples of African or Chinese origin. The presence of the 1.9 kb XhoI fragment ( Fig. 3 ) characteristic of the B95-8 prototype strain was evident in all the African samples, but was replaced in the Chinese samples with larger fragments ranging in size between 6 and 11 to 12 kb (a).
Of a total of 19 NPC biopsies of North or East African origin and 37 Chinese NPC biopsies tested, Fig. 2 includes two NPC biopsies of North African origin (C82 and C121), one nude mouse-propagated North African NPC (C 15) and two NPC biopsies of East African origin (SD and OM), as well as seven Chinese NPC biopsies (N8, Nil, N17, N40, N41, N45 and N48) and one nude mouse-propagated NPC, CAO. The classification of these materials according to EBV (EBNA 2) serotype A or B and LMP expression is shown in Fig. 2 (b) . There was only one exception to the difference in XhoI polymorphism between African and Chinese samples shown in Fig. 2 . Of the 37 Chinese biopsies, 32 were type L.-F. Hu The first eight lanes represent NPC biopsies and cell lines of East or North African origin, whereas the other 10 lanes represent NPC tumour material and cell lines established from Chinese individuals in the Shanghai area or from southern China. The size marker was a 1 kb restriction fragment ladder (BRL). The 1.9 kb band indicated corresponds to the fragment size predicted from the B95-8 sequence (Baer et al., 1984) . Additional bands of larger size in the C 121, C 15 and OM samples are partial XhoI cleavage products. The heterogeneity of the large (6 to 12 kb) fragments in the Chinese samples is explained by the inclusion in these fragments of the Nhet repeats at the right end of the EBV genome (Raab-Traub & Flynn, 1986 A and five were type B. Three of the Chinese type B-carrying NPCs and three CBC lines established from healthy donors (two samples), or a N P C patient (one sample) were tested for XhoI polymorphism in LMP1 and were found to lack the XhoI site (Table 2) .
Thus, EBV strains prevalent in China frequently carry a rearrangement affecting the sequence of the XhoI sites flanking the 1-9 kb XhoI fragment detected in B95-8 using an L M P 1 probe. The mapping data indicate that this, in all probability, is the XhoI site at the 5' end of the coding sequence of LMP1, since each tumour has a XhoI fragment of unique size, indicating that the variable Nhet region at the right end of the viral genome is contained in the fragment (Fig. 3) . Such in vivo variation in the size of the Nhet repeat region has been observed previously as a distinctive characteristic of the monoclonal origin of individual N P C tumours (Raab-Traub & Flynn, 1986; Lung et al., 1990) .
Restriction mapping of the B a m H I Nhet fragment in the phage 2 clone CAO-5 Fig. 3 shows a comparison of the restriction maps for the B95-8 (a) and CAO (b) BamHI Nhet fragments using a number of restriction enzymes. The map shows that the 5" XhoI site in the coding region of the LMP1 gene is absent from the CAO isolate, and also demonstrates the loss of the two internal NcoI sites present in the LMP1 gene of the B95-8 isolate. The Nhet region (EcoRI to SaclI) in the 2 SK 10 CAO-5 clone shown in Fig. 3 was 1.4 kb in length. This corresponds to the size of the Nhet fragment in the original nude mouse tumour CAO, but is 0.7 kb shorter than that in the B95-8 prototype strain.
A comparison of 10 different BamHI Nhet clones
derived from the SK10 library of the CAO tumour also revealed a size variation which could not be accounted for by variation in the D N A from the tumour. From this, and o u r subsequent mapping data, we drew the conclusion that rearrangements had occurred in the Nhet region of the insert in the phage 2 vector, perhaps as a result of recA-mediated recombination between reiterated sequences in Nhet. For instance, the Nhet fragment in another m a p p e d clone, SK10-CAO-6, was reduced to 0.4 kb in length (Fig. 3) . For further analysis, mapping with different restriction enzymes and expression studies, the phage 2 CAO-5 clone was chosen.
Comparison between the DNA sequences of the CAO, B95-8, Raft and C15 LMP1 genes, and their promoter and enhancer sequences
In Fig. 4 , the D N A sequences for the LMP1 gene from the four EBV isolates have been aligned to show changes in the sequence. The 2038 bp CAO sequence is 9 5~ identical to the B95-8 and 9 4~ identical to the Raji LMP1 sequences. Divergent sequences appear to be clustered around the proposed binding site for NF-1 at nucleotides -2 4 0 to -2 3 0 from the transcription start, and from the putative Oct-l-binding site at -1 4 0 to -100 (Ghosh & Kieff, 1990 XhoI site (Fig. 3) is caused by a point mutation altering and the production, instead, of a single larger fragment is detected using the 1671 bp Sinai probe, of indicating that both the BglI sites are lost.
CAO GCC~ ~CCCAACCTTGCGC CC C CCGC~ CCT CTTT GT CCAGATTACACT GC C GCTT CCCACAACACI ACTCAC T CCCCC
Measurements of the size of the repeat sequence are shown in Fig. 5 , using a combination of either BglII (position 169037) and ApaI (relevant position 168314), or StyI (relevant position 168 597) and ApaI. The shift in the size of fragments detected with both enzyme combinations between the B95-8 and CAO repeat segments corresponds closely to that predicted by the DNA sequences (BglII and ApaI, 723 to 807 bp; and StyI to ApaI, 283 to 367 bp for B95-8 and CAO respectively).
Comparison of the amino acid sequences of the LMP1 protein ofB95-8, CAO and Raft
The overall size of the CAO LMP1 protein is 404 aa, compared to 386 aa for the other strains. Fig. 6 shows the alignment of the amino acid sequences for the LMP1 proteins of the three virus strains. If the gross rearrangements in the C-terminal part of the protein are not taken into account, the values for amino acid similarity can be calculated on the basis of net shared sequences, which amount to 371 aa. Therefore, the amino acid similarity between B95-8 and CAO is 92 ~, and between Raji and CAO 91 ~, whereas B95-8 is 95~ similar to Raji. The most significant divergence in sequence is in the first 
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R S * * * * * * * * * * T (404) D I T Fig. 6 . Comparison of the amino acid sequences of EBV strains B95-8, CAO and Rail. Amino acid residues are represented in the single letter code. Only those residues of the sequences of the CAO and Raji strains of EBV which differ from that of the B95-8 strain are indicated. The main structural features of the LMPI protein have been marked as subscripts: transmembrane segments are labelled m, segments exposed on the cell surface x; the proteolytic cleavage site for post-translational processing of the LMP1 protein (Moorthy & Thorley-Lawson, 1990 ) has been marked > < , and the seven, l I or 16 aa repeat sequences are indicated by/7,/l I or/16; deletions are marked by an asterisk. 8) and Rhek-I (lanes 9 to 1 l) cells by electroporation as described in Methods. LMP1 protein was detected on the immunobtots using monoclonal antibody S12 (Mann et al., 1985) . electroporated into DG75, B JAB and Rhek-1 cells as described above. After 40 h, cell lysates were prepared for immunoblotting to determine whether the expression clones were capable of directing the expression of a serologically reactive protein of the anticipated size. The immunoblots in Fig. 7 demonstrate that the correctly sized protein products were expressed in all the transfected cell lines. The J124-CAO-5 plasmid produced a larger protein (66K) than the isogenic construct J132-G5 expressing the B95-8 LMP1 gene (63K; Fig. 7 ). This agrees with the larger size predicted from the amino acid sequence, and is consistent with the size of the protein detected in the CAO tumour. Although the constructs were essentially identical, and the conditions of electroporation were standardized, the CAO LMP1 gene was consistently expressed at a higher level than the B95-8 construct.
Discussion 20 aa, representing the intracytoplasmic N terminus of the protein. In this region, the similarity between CAO, and B95-8 and Raji LMP1 drops to 65~ and 60~o respectively; B95-8 and Raji are 90~o identical in this region. The N-terminal 20 aa may be divided into two parts on the basis of charge distribution. Amino acids 1 to 6 have a predominantly acidic charge due to the three acidic residues at positions 2, 4 and 6; the segment from aa 7 to 20 has four basic residues and three proline pairs. The three non-conservative substitutions in the CAO LMP1 protein in this segment replace three of the four basic amino acids with non-polar or uncharged residues, thereby altering the overall charge of the N terminus. It should be noted that the insertions in the repeat region of the C-terminal part of the CAO LMP1 protein, as well as the deletions in and after this region, are all located after the proteolytic cleavage site between aa 241 and 242 for the post-translational processing event that releases the 145 aa (25K) phosphorylated fragment of LMP 1 of other EBV strains into the cytoplasm (Mann & ThorleyLawson, 1987; Baichwal & Sugden, 1987; Moorthy & Thorley-Lawson, 1990 ); this C-terminal fragment will consist of 163 aa in CAO.
Expression of the CAO LMP1 gene in human lymphoid cell lines and immortalized keratinocytes
Expression vector clones of the B95-8 and CAO-5 LMP 1 genes under control of the EDL1 (B95-8 coordinates 170153 to 166614) and the SV40 promoters (Fig. 3) were
We have cloned and sequenced the BNLF-1 gene (LMP1) from a Chinese NPC to establish whether it shows major differences compared to previously sequenced, B cell-derived EBV strains. We have found that the LMP1 gene of the CAO tumour differs considerably from the corresponding gene in the B95-8, Raji and C15 isolates. The XhoI polymorphism detected in the LMP1 gene is also present in the EBV genomes associated with 36 of 37 NPC biopsies from the Shanghai area and the Guangdong province in Southern China, but were not found in 17 of the 19 NPC biopsies of North and East African origin studied. This indicates that RFLP markers may be of use for studies of the epidemiology of NPC in relation to EBV strain variation. Taken together with our analysis of the EBNA 2 type of the biopsies (Table 2) it also indicates that, in all probability, the EBV genome present in the CAO tumour represents a substrain of EBV type A which is widespread in China, since practically all our Chinese biopsies show the same RFLP pattern with respect to the LMP1 XhoI site. Furthermore, the LCLs established from two healthy donors and one NPC patient from China (Table 2) were identical to the majority of the Chinese NPC biopsies with regard to the XhoI polymorphism. It is puzzling, however, that the three type B biopsies analysed also do not contain the LMP1 XhoI site.
The relevance of the LMP1 gene to NPC relies on the phenotypic effects observed in transfected human keratinocytes. Not only does LMP 1 arrest the keratinous differentiation of epithelial cells in culture (Dawson et al., 1990) , but transfectants show morphological changes perhaps related to an observed reduction in the synthesis of certain cytokeratins (Dawson et al., 1990; F~hraeus et al., 1990a) . Further evidence for an effect of the LMP1 gene on keratin expression is provided by the hyperexpression of keratin 6 detected in epidermis and tongue tissue of transgenic mice expressing the LMP1 gene (Wilson et al., 1990) . LMP1 is also the only growth transformation-related EBV gene which is expressed, besides EBNA 1, in NPC biopsies (F~hraeus et al., 1988; Young et al., 1988) , and has been implicated as a transforming gene by its ability to transform rodent fibroblasts to anchorage-independent growth and tumorigenicity in nude mice (Baichwal & Sugden, 1988; Wang et al., 1985 Wang et al., , 1988 .
The LMP1 gene isolated from the Chinese NPC CAO shares basic structural features with the LMP1 genes of sequenced B95-8, Raji and C15 strains (Baer et al., 1984; Hatfull et al., 1988 ; Gilligan et al., 1990) . It shows several structural changes that may have arisen as a result of random genetic drift, but which may also have functional significance. The latter is suggested by the base substitutions clustered in the promoter/enhancer part of the LMP1 cistron (Fig. 4) . These may influence the binding of transcription factors (Ghosh & Kieff, 1990) or may affect the function of the cell-specific negative regulatory element mapped between nucleotides -106 and -54 (Fhhraeus et al., 1990b) . Our preliminary studies of the methylation state of this promoter/enhancer region in Chinese NPC biopsies, using HpalI and MspI cleavage, also confirms the addition of new sites at nucleotides -126 and -517, and the loss of the B95-8 site at -207, which indicates that regulation of the EDL1 promoter activity by methylation may be altered in the CAO strain.
The peculiar distribution of amino acid substitutions found in the short intracytoplasmic N terminus of the CAO LMP1 protein demonstrates that this domain is not conserved in all EBV strains (Fig. 6 ). Transformation studies with LMP deletion mutants suggest, however, that the N-terminal domain is important for the transforming activity of the B95-8 LMP 1 gene (Baichwal & Sugden, 1989; Hammerschmidt et al., 1989) .
The structure of the seven perfect direct repeats of 33 bp, which are preceded by a 21 bp sequence representing a subset of the 33 bp repeat unit, is remarkable. Size differences in the LMP1 protein have been noted previously in different cell lines derived from BL. Of particular interest is the observation that the BL line WeWak-1 expresses an LMP1 protein of significantly lower molecular size than that of B95-8, and that this protein appears to lack some or all of the antigenic determinants of the amino acid sequence HDPLPQDPDN (aa 276 to 285; Fig. 6 ), because a peptide antibody directed against this repeat unit fails to detect the WeWak-1 LMP1 protein (Rowe et al., 1986) . The CAO isolate lacks HDPLP of this decapeptide. The 33 bp repeat region of LMP1 thus appears to be a target for rearrangement in vivo. Apart from the EBNA 1 protein of EBV, the glycine-alanine-rich repeat of which also varies in size between isolates, other examples of viral proteins with variable repeat regions include the glycoprotein C homologue of varicella-zoster virus (Kinchington et al., 1986) , which has a variable copy number of a 14 aa repeat, and the 39K surface protein of fowlpox virus (Binns et al., 1990) , in which the 12 aa repeat contains dominant immunogenic epitopes.
We believe that the extended repeat structure in the coding sequence of the CAO LMP1 gene, as well as the two C-terminal deletions and the polymorphic restriction sites found in the DNA sequence, faithfully reflect the structure of the original gene in the CAO tumour. First, a recA-mediated rearrangement would be expected to yield deletions like those observed in the Nhet repeats in our phage 2 clones. In addition, a direct comparison of polymorphic restriction sites and RFLPs between EBV DNAs extracted from the B95-8 and CAO tumour cells (Fig. 5) confirm the existence in viral episomes of the original CAO nude mouse tumour of the structural alterations predicted from the DNA sequence of the cloned gene. Furthermore, despite the deletions and insertions found in the sequence of the CAO LMP1 gene, the open reading frame is preserved, and expression of the cloned and sequenced gene in two B cell lines, DG-75 and BJA-B, and in a human keratinocyte line, Rhek-1 (Fig. 7) , produces an LMP1 protein with electrophoretic mobility identical to that detected in the CAO tumour material. Preliminary functional comparison of the CAO and the B95-8 LMP1 genes (L.-F. Hu, F. Chen, I. Ernberg, G. Klein & G. Winberg, unpublished results) shows that expression of either gene renders human Rhek-I keratinocytes capable of anchorage-independent growth but demonstrates, in addition, that although the untransfected Rhek-1 cells, vector control clones and B95-8 LMPl-transfected Rhek-1 cells (nine clones tested) fail to produce tumours in SCID mice, nine of 24 clones of Rhek-I cells transfected with the CAO LMP1 gene produce tumours, some of which grow invasively into surrounding tissue. These tumours express the CAO LMP1 gene and display human histocompatibility markers.
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